Inventor · disambiguated record
Kexin Huang
Also filed as: HUANG KEXIN
6 granted patents·4 pending applications·9 citations·filing 2017–2024
76Inventor score
Files withHOPE CITY3AKSTON BIOSCIENCES CORP2ALLINAIRE THERAPEUTICS LLC1LAKEPHARMA INC1SUNSTELLA TECH CORPORATION1
Top patents by PatentIndex Score
10 records- 0195US11213581B2Antigen specific immunotherapy for COVID-19 fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Jan 4, 2022·3 cites·27 claims
- 0285US11981740B2BAFF-R antibodies and uses thereofHOPE CITY·Filed 2021·Granted May 14, 2024·1 cites·20 claims
- 0385US11136405B2BAFF-R antibodies and uses thereofHOPE CITY·Filed 2017·Granted Oct 5, 2021·3 cites·14 claims
- 0478US12343393B2Antigen specific immunotherapy for COVID-19 fusion proteins and methods of useVAKSTON INC·Filed 2023·Granted Jul 1, 2025·0 cites·20 claims
- 0576US11707517B2Antigen specific immunotherapy for COVID-19 fusion proteins and methods of useAKSTON BIOSCIENCES CORP·Filed 2021·Granted Jul 25, 2023·0 cites·16 claims
- 0676US11554181B2Tumor specific antibody conjugates and uses thereforUNIV NORTH CAROLINA CHARLOTTE·Filed 2019·Granted Jan 17, 2023·2 cites·18 claims
- 0775US2024287200A1Baff-r antibodies and uses thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 0859US2023034559A1Automated prediction of clinical trial outcomeSUNSTELLA TECH CORPORATION·Filed 2022·Application pending·0 cites
- 0948US2023287095A1Humanized anti-emap ii therapeutic antibodiesALLINAIRE THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 1038US2020339686A1Bispecific antibody that binds cd3 and another targetLAKEPHARMA INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kexin Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →